M Sue Kirkman

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Glycemic Control

Clinical Practice

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

David B Sacks, M Sue Kirkman, Randie R Little
Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use. Diabetes care 47 (7) (2024)
David B Sacks, M Sue Kirkman, Randie R Little
Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use. Diabetes care (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
David B Sacks, M Sue Kirkman, Randie R Little
Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use. Diabetes care 47 (7) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
M Sue Kirkman, Mark Tripputi, Heidi Krause-Steinrauf, Ionut Bebu, Hiba AbouAssi, Henry Burch, Elizabeth Duran-Valdez, Hermes Florez, W Timothy Garvey, Daniel S Hsia, Maamoun Salam, Pradipta R Ray, null null
Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes care 47 (4) (2024)
David B Sacks, M Sue Kirkman, Randie R Little
Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use. Diabetes care 47 (7) (2024)
David B Sacks, Mark Arnold, George L Bakris, David E Bruns, Andrea R Horvath, Lernmark Åke, Boyd E Metzger, David M Nathan, M Sue Kirkman
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes care (2023)
David B Sacks, Mark Arnold, George L Bakris, David E Bruns, Andrea R Horvath, Lernmark Åke, Boyd E Metzger, David M Nathan, M Sue Kirkman
Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes care (2023)
Daria Igudesman, Jamie L Crandell, Karen D Corbin, Dessi P Zaharieva, Ananta Addala, Joan M Thomas, Anna Casu, M Sue Kirkman, Teeranan Pokaprakarn, Michael C Riddell, Kyle S Burger, Richard E Pratley, Michael R Kosorok, David M Maahs, Elizabeth J Mayer-Davis, null null
Weight management in young adults with type 1 diabetes: The advancing care for type 1 diabetes and obesity network sequential multiple assignment randomized trial pilot results. Diabetes, obesity & metabolism (2022)
Richard I G Holt, J Hans DeVries, Amy Hess-Fischl, Irl B Hirsch, M Sue Kirkman, Tomasz Klupa, Barbara Ludwig, Kirsten Nørgaard, Jeremy H Pettus, Pr Eric Renard, Jay S Skyler, Frank J Snoek, Tracey D Brown, Anne L Peters
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes care 44 (11) (2021)
Klara R Klein, Jennifer L R Freeman, Imogene Dunn, Chris Dvergsten, M Sue Kirkman, John B Buse, Carmen Valcarce, null null
The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes. Diabetes care 44 (4) (2021)